Developing products that are first-in-class with unique mechanism of action and are different from those of existing therapies

Pharmazz, Inc.

Pharmazz, Inc. is an innovative biopharmaceutical company with an approved product, promising drug pipeline and a seasoned management team. It is a Delaware Corporation based in Willowbrook, Illinois, USA focused on discovering, acquiring, developing, and commercializing therapeutics that target critical care medicine. Pharmazz India Private Limited a majority owned subsidiary of Pharmazz, Inc. obtained marketing authorization of Lyfaquin® (INN: Centhaquine) in India.

Pharmazz has licensed exclusive worldwide rights to several molecules indicated for critically ill patients from Midwestern University, Downers Grove, USA. The company has a strong patent position and robust pipeline in different stages of clinical development.

More About Us
about

Product Pipeline

Products Pre-Clinical Clinical Market
Phase 1 Phase 2 Phase 3
Hypovolemic Shock (Centhaquine - Lyfaquin®)
Septic Shock (Centhaquine)
Acute Kidney Injury (Centhaquine)
Cardiac Arrest (Centhaquine)
Cerebral Ischemic Stroke (Sovateltide)
Alzheimer's Disease (Sovateltide)
Acute Spinal Cord Injury (Sovateltide)
Diabetic Ketoacidosis (PMZ-2123)
Opioid Tolerance (PMZ-2123)
backgrounds

Management

The management team is well balanced with significant drug development and clinical expertise, and commercialization experience. In addition to the management and development team in the US, the company has over 80 employees through its subsidiary in India.

More Details

Media Coverage

icon

Recently Pharmazz India Private Limited

Mar. 19, 2019, - New Delhi, India.-- Recently Pharmazz India Pvt Ltd presented its nine years of research done for developing life saving drugs..

icon

रक्त बहने से होने वाली मौत रोकने की दवा ईजाद

Mar. 14, 2019, - New Delhi, India -- राज एक्सप्रेस, नई दिल्ली। वैज्ञानिकों ने करीब नौ वर्षों के शोध के बाद ऐसी दवाइयों को ईजाद किया है, जिससे अत्यधिक..

icon

रक्त बहने से होने वाली मौत रोकने की दवा ईजाद

Mar. 14, 2019, - New Delhi, India -- राज एक्सप्रेस, नई दिल्ली। वैज्ञानिकों ने करीब नौ वर्षों के शोध के बाद ऐसी दवाइयों को ईजाद किया है, जिससे अत्यधिक..